Skip to content
Search

Latest Stories

Pharmacy First vital to amplify NHS digital prescription rollout, WHO report reveals

Pharmacy First vital to amplify NHS digital prescription rollout, WHO report reveals
75 per cent of adults in England are registered for digital prescriptions on the NHS App

In a groundbreaking move towards modernising healthcare, England's National Health Service (NHS) has successfully implemented digital prescriptions, as reported by the World Health Organization (WHO) in its latest regional digital health report.

Since January 2024, patients across England have had access to their prescription information through the NHS App, marking a significant leap in healthcare accessibility and efficiency.


With over 33 million registered users, representing 75 per cent of the adult population, the NHS App has become a vital tool in managing healthcare online.

The introduction of digital prescriptions allows users to order repeat prescriptions online without the need for a GP visit.

This innovation has witnessed a surge in digital requests, with over 3.1 million repeat prescriptions processed monthly.

Notably, this digital approach saves GPs an average of three minutes per prescription, leading to substantial time and cost savings for health centers.

Moreover, the launch of Pharmacy First has aided the NHS to lessen the burden on the GPs as pharmacies are assisting patients for common conditions including sore throat, shingles and  uncomplicated cases of UTIs. 

The report revealed that Pharmacy First scheme "is likely to lead to an increase in patients visiting pharmacies, so the App’s efficiencies for prescriptions will become ever more important".

Natasha Lane, Senior Programme Manager for Digital Medicines at NHS England, highlighted the gradual rollout and refinement of digital prescriptions, emphasising the importance of user feedback in enhancing the App's functionality and usability.

Commenting on the user experience and accessibility, she said "patients no longer have the inconvenience of having to go to a prescriber to collect a paper barcode.”

The benefits extend beyond healthcare providers, with Secretary of State for Health and Social Care Victoria Atkins acknowledging the tool's role in alleviating pressure on pharmacists and GPs, thereby reducing waiting lists and improving patient care.

Moreover, the integration of digital prescriptions into the NHS App enhances transparency within the healthcare system, empowering patients to take ownership of their health.

With over 500,000 weekly views of digital prescriptions, patients can now conveniently access their prescription information and address any concerns promptly, ultimately reducing delays and streamlining the healthcare process.

Furthermore, the WHO's report underscores England's pioneering role in digital healthcare within the European Region.

While England leads with digital prescription implementation, other European countries have also embraced electronic prescriptions, with some even establishing interoperable systems for cross-border prescriptions.

This digital transformation aligns with WHO/Europe's strategic objectives to enhance patient safety, quality of care, and universal health coverage.

By leveraging digital tools, healthcare systems can effectively address the evolving needs of patients and healthcare professionals alike.

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less